Recalls for Bupivacaine

1% Lidocaine HCL Injection By Hospira: Recall - Presence Of Dark Particulate
10/05/2013 Medical Recall

May result in local inflammation, phlebitis, and/or low-level allergic response, and could block administration of the drug to the patient, causing a delay in therapy.

  • Company:
    Hospira